Evidence map›Paper›PMID 35001940›Full record

ArticleCoordination chemistry reviews2022

BODIPY based Metal-Organic Macrocycles and Frameworks: Recent Therapeutic Developments.

Gajendra Gupta, Yan Sun, Abhishek Das, Peter J Stang, Chang Yeon Lee

Abstract read
In one paragraph

Article in Coordination chemistry reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Advances in BODIPY Derivatives for Antibacterial Phototherapy.Angewandte Chemie (International ed. in English) · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Aggregation-Driven Photoinduced α-C(spJournal of the American Chemical Society · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gajendra GuptaDepartment of Energy and Chemical Engineering/Innovation Center for Chemical Engineering Incheon National University, 119 Academy-ro, Yeonsu-gu, Incheon 22012, Republic of Korea.
Yan SunDepartment of Chemistry, University of Utah, Salt Lake City, Utah 84112, United States.
Abhishek DasDivision of Molecular Medicine, Bose Institute, Kolkata, West Bengal 700054, India.
Peter J StangDepartment of Chemistry, University of Utah, Salt Lake City, Utah 84112, United States.
Chang Yeon LeeDepartment of Energy and Chemical Engineering/Innovation Center for Chemical Engineering Incheon National University, 119 Academy-ro, Yeonsu-gu, Incheon 22012, Republic of Korea.

Funding

Active Delivery of Platinum Nanoimmunoconjugates to Improve Breast Cancer TherapyR01CA215157 · NCI · PROTEOGENOMICS RESEARCH INSTIT/SYS/ MED · PI OLENYUK, BOGDAN, STANG, PETER J · 2017 to 2021
$2.3M
NCI NIH HHS R01 CA215157
6 · The paper itself

Abstract

Boron dipyrromethene, commonly known as BODIPY, based metal-organic macrocycles (MOCs) and metal-organic frameworks (MOFs) represent an interesting part of materials due to their versatile tunability of structure and functionality as well as significant physicochemical properties, thus broadening their applications in various scientific domains, especially in biomedical sciences. With increasing concern over the efficacy of cancer drugs versus quality of patient's life dilemma, scientists have been trying to fabricate novel comprehensive therapeutic strategies along with the discovery of novel safer drugs where research with BODIPY metal complexes has shown vital advancements. In this review, we have exclusively examined the articles involving studies related to light harvesting and photophysical properties of BODIPY based MOCs and MOFs, synthesized through self-assembly process, with a special focus on biomolecular interaction and its importance in anti-cancer drug research. In the end, we also emphasized the possible practical challenges involved during the synthetic process, based on our experience on dealing with BODIPY molecules and steps to overcome them along with their future potentials. This review will significantly help our fellow research groups, especially the budding researchers, to quickly and comprehensively get the near to wholesome picture of BODIPY based MOCs and MOFs and their present status in anti-cancer drug discovery.

Indexed as

BODIPYFluorescenceMetal Organic FrameworksMetal Organic MacrocyclesTherapeutic

Identifiers

PMID35001940
PMCPMC8730361

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.